Visit our news section for more articles.
News Our full Mednous news archive Appointments Latest industry appointments Events A list of upcoming industry events
Evernow Publishing Ltd Privacy Policy. Read more.
Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.
The latest MedNous journal. Subscribe to download.
Italy
Chiesi Farmaceutici SpA has pledged to invest €350 million over five years to bring a new formulation of inhaler for respiratory diseases to the market with the goal of reducing the carbon footprint of these devices. The company is believed to be the first in the pharmaceutical industry to publicly commit to a lower the carbon footprint for aerosol inhalers. It announced the plan at the United Nations Climate Change Conference on 4 December.
United States
New long-term data for the cancer therapy Yescarta (axicabtagene ciloleucel) have shown that nearly half of patients treated with the cell-based gene therapy were alive three years after treatment. The long-term data were presented on 7 December at the American Society of Hematology meeting in the US, and are similar to outcome data reported in 2017.
United Kingdom
The UK medical charity LifeArc has extended a research collaboration with Metrion Biosciences Ltd with the goal of identifying new compounds for neurological diseases using Metrion’s ion channel drug discovery technology. The year-old collaboration is being extended for a further 12 months.
France
Germany
Netherlands
Switzerland
Switzerland
United Kingdom
Switzerland
Germany
United States
Germany
Visit our news section for more articles.
News Our full Mednous news archive Appointments Latest industry appointments Events A list of upcoming industry events
© 2019 Evernow Publishing Ltd. Powered by Drupal.